Alira Health

What Alira Health does

Alira Health is a global healthcare advisory and contract research organization (CRO) that delivers integrated services across the pharmaceutical, biotechnology, MedTech, and digital therapeutics value chain. Founded in 1999, the firm operates with 800+ employees (over 90% holding PhD and/or Masters degrees across 30 nationalities and 15 languages) and serves 450+ clients in more than 30 countries, including 75% of the top 50 global pharma companies and 80% of the top 50 global MedTech companies. The company is headquartered in Framingham, Massachusetts with operational offices across the United States, France, Italy, Spain, the Netherlands, Germany, and Austria, and is privately held with backing from private equity firm Creadev.

The company's offering combines full-service CRO capabilities (regulatory, clinical operations, biometrics, CMC, and clinical development consulting), strategic consulting (management consulting, market access, patient engagement, and transaction advisory), real-world evidence generation, and proprietary technology platforms. The core technology assets are SpherePX™, a patient-enabled platform for regulatory-grade real-world evidence and post-market studies, and Health Storylines™, a patient-driven digital ecosystem supporting decentralized trials with over 150,000 enrolled patients. Proprietary patient registries (Lupus Registry, AXIS Registry) and an AI Assistant Creator for automated study support and data extraction differentiate the platform. The Patient Engagement Certification, launched in mid-2025 at $750 per enrollee, extends the platform into credentialing and training.

Alira Health has executed an aggressive acquisition strategy to build its integrated model, completing at least seven acquisitions between 2018 and 2022, including Cros NT (Italy, 2021), BEPATIENT (2021), PatchAi (2021), Self Care Catalysts (2022), RedCrow (2022), Sourcia (Netherlands/Germany/Austria, 2022), and Artisan Healthcare Consulting (North America, 2022). The firm has raised $133 million in equity (including a $40M round led by Creadev in January 2022 and $58M in January 2023) and secured a $100 million growth debt facility from Symbiotic Capital in December 2024. Revenue is generated primarily through professional services contracts with enterprise healthcare and life sciences organizations, supplemented by platform licensing and recurring certification fees.

Name

Alira Health

Legal name

Alira Health

Website

https://alirahealth.com

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Alira Health is a global healthcare advisory and CRO serving 450+ pharma, biotech, and MedTech clients across 30+ countries via integrated clinical, regulatory, consulting, and proprietary real-world evidence platforms (SpherePX, Health Storylines).

Ownership category

akta.pro rank

Product category

Healthcare Advisory Services

NAICS

Other Scientific and Technical Consulting Services (54169), All Other Professional, Scientific, and Technical Services (54199)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Management Consulting Services (8742), Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industries

Real-World Evidence (RWE), HEOR & Epidemiology CROs (HLAGAAAK), Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM), Regulatory Strategy & IND/NDA/BLA Submissions Support (HLAIALAH), Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL), Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI), Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF)

Keywords

• Contract research organization
• Healthcare consulting services
• Patient engagement solutions
• Clinical development services
• Real-world evidence platforms

Headquarters

HQ city

Paris

HQ country

France

HQ region

Europe

Offices6 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. CRO Services (Contract Research Organization): Full-service CRO offering clinical trial support across all phases and therapeutic areas. Services include regulatory, clinical operations, biometrics, CMC, and clinical development consulting delivered by multidisciplinary expert teams.
2. Healthcare Consulting: Strategic consulting services including management consulting, market access, patient engagement, and transaction advisory. Teams include management consultants, medical professionals, and clinical experts offering deep industry knowledge.
3. Technology Platform Licensing: Technology platforms including SpherePX for real-world evidence and Health Storylines for patient engagement. Platform supports regulatory-grade data collection and patient-reported outcomes.
4. Patient Engagement Certification: Training and credentialing program at $750 per individual with team enrollment options available. Self-paced online certification across 7 modules with digital credential awarded upon completion.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Core offering

Alira Health provides integrated advisory, contract research organization (CRO), and patient-engagement technology services to healthcare and life sciences organizations. The firm combines full-service clinical development capabilities (regulatory, clinical, biometrics, CMC), management consulting, market access, transaction advisory, and proprietary technology platforms (SpherePX™ and Health Storylines™) for decentralized trials and real-world evidence generation. Its client base includes 75% of the top 50 global pharma companies and 80% of the top 50 global MedTech companies across more than 30 countries.

Product overview

Alira Health offers a comprehensive suite of integrated services designed for healthcare and life sciences organizations, combining technology platforms with expert consulting services. The core technology platforms include SpherePX™ (a patient-enabled platform for real-world evidence and post-market studies) and Health Storylines™ (a patient-driven digital ecosystem for decentralized trials and patient support). The service portfolio spans Research & Clinical Development (full-service CRO covering regulatory, clinical, biometrics, CMC), Consulting (management consulting, market access, patient engagement, transaction advisory), and Real-World Solutions. Specialized therapeutic and sector expertise includes Autoimmune, Biosimilars, CDMO Biologics Advisory, CDMO Medtech Advisory, Nuclear Medicine, Rare Disease, and Wound Care. The company also offers a Patient Engagement Certification program. Together, these offerings enable end-to-end support from clinical development through commercialization, with a focus on patient-centered solutions.

Differentiator

Problem solved

Functional benefit

Brands

• SpherePX™: Patient-enabled platform for real-world evidence capturing patient data for healthcare innovation
• Health Storylines™

Products and services

• SpherePX™ A flexible, modular patient-enabled platform that streamlines the design, launch, and execution of post-market studies, delivering regulatory-grade, real-time evidence grounded in patient experience. Supports regulatory-grade registries, PASS, LTFU, CER, hybrid studies, and label expansion/reimbursement workflows for life sciences sponsors.
• Health Storylines™ A patient-driven digital ecosystem supporting decentralized trials, real-world evidence generation, and patient support programs. Captures the voice of the patient for healthcare innovation and integrates with multi-language, multi-setting clinical operations.
• Patient Engagement Certification (PEC) A self-paced certification program across 7 modules for life sciences professionals to learn compliant patient engagement practices throughout the product lifecycle. Priced at $750 per individual with team enrollment options and a digital credential awarded upon completion.
• Research and Clinical Development Solutions Full-service CRO offering covering regulatory, clinical operations, biometrics, CMC, and clinical development consulting for studies in all phases across a wide range of therapeutic areas. Delivered by multidisciplinary expert teams including strategists, doctors, bankers, and scientists.
• Consulting Services Strategic consulting services for healthcare and life sciences organizations, including management consulting, market access and pricing/reimbursement strategy, patient engagement advisory, and transaction advisory (M&A buy-side/sell-side, licensing, divestment, and asset sales).
• Real-World Solutions Evidence generation services including data strategy, real-time data capture, clinical solutions for virtual trials and real-world evidence, patient registries, and HEOR-driven market access studies.
• Biotech Services Agile and holistic solutions for biotech companies spanning drug development support, funding strategy, and execution delivered through full-service CRO and regulatory teams. Targets both startup and mid-market biotechs across multiple therapeutic areas.
• Autoimmune Solutions Integrated support for autoimmune solution development leveraging real-world data and 15+ years of expertise across 40+ immunology indications, including dedicated registries and patient engagement capabilities.
• Rare Disease Solutions Development and commercialization support for rare disease treatments with a patient-centric approach covering clinical trials, patient recruitment, regulatory strategy, and reimbursement across 100+ rare diseases.

Quantifiable outcome

• 5000+ app downloads for virtual site studies
• +2 more outcomes

Named customers12 records

Segments6 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature4 records

Partnerships

Four partnerships are on record, tiered core.

• Patient Focused Medicines Development (PFMD)coreStrategic or Co-development PartnerAlira Health announced its partnership with PFMD, a coalition dedicated to enabling patient engagement by providing frameworks and collaborative networks needed to make patient-centered healthcare a worldwide reality. This partnership advances patient-centered evidence generation.
• Autoimmune Neurology Alliance (AiNA)coreStrategic or Co-development PartnerAlira Health partnered with AiNA to launch the AXIS Registry, a US-based 10-year longitudinal study advancing real-world and patient-centered research in autoimmune neurology.
• Gustave RoussycoreTechnology or IntegrationOne of the world's top cancer research institutes has integrated Alira Health's SpherePX technology into Project Interception to advance cancer prevention. The partnership develops personalized prevention programs for people at high risk of cancer.
• EURORDIScoreStrategic or Co-development PartnerAlira Health is a proud member of EURORDIS' European Roundtable of Companies (ERTC), sharing their mission of raising awareness about rare diseases and their impact on patients' lives.

Scale indicators9 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Parexel: Global CRO with strong regulatory, clinical, and real-world evidence capabilities serving pharma and MedTech. Comparable across CRO, regulatory strategy, and RWE service lines.
• ICON plc: Global full-service CRO offering clinical, biometrics, consulting, and laboratory services to pharma and MedTech. Directly comparable to Alira Health's CRO and consulting model, with deeper scale and broader therapeutic reach.
• Medpace: Mid-sized full-service CRO with strong biotech and MedTech exposure, offering clinical operations, biometrics, and regulatory services. Closely comparable to Alira Health's CRO services and biotech customer segment.
• Syneos Health: Biopharmaceutical solutions organization combining CRO services with commercial and consulting offerings. Directly comparable in integrated clinical-to-commercial model, now private under Elliott/Veritas.
• Cytel: Specialty biometrics and biostatistics CRO with strong statistical programming and data management focus. Closely comparable to Alira Health's biometrics service line and CDISC/centralized biometrics capabilities.
• Trinity Life Sciences: Life sciences strategic consulting firm offering management consulting, market access, and commercial diligence for pharma and MedTech. Comparable to Alira Health's consulting, market access, and transaction advisory practices.
• Precision Medicine Group: Specialized services provider for emerging biotech and pharma covering clinical, regulatory, commercial, and lab services. Comparable to Alira Health's biotech-focused CRO and consulting offerings.

Broad incumbents

• IQVIA: The largest global CRO and healthcare data/analytics provider. Overlaps with Alira Health across clinical operations, real-world evidence, consulting, and technology, but at vastly greater scale and breadth.
• Fortrea (Labcorp Drug Development spinoff): Spun out CRO offering clinical, biometrics, and central laboratory services. Directly comparable in clinical CRO services and biometrics, with broader scale and lab capabilities.
• Charles River Laboratories: Preclinical and clinical CRO plus manufacturing services for pharma and biotech. Overlaps with Alira Health in CMC/biologics advisory and clinical operations but with a much larger preclinical and manufacturing footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/alirahealth
• LinkedInlinkedin.com/company/alira-health
• Instagraminstagram.com/alirahealth
• Facebookfacebook.com/AliraHealth

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles21 records

Subsidiaries6 records

Funding overview

Funding rounds4 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A10 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Alira Health